Steering Committee

Rick Ellion, MD

Chairman - HIV Steering Committee
Associate Clinical Professor of Internal Medicine, George Washington University
Private Practice - Washington DC

Keri Althoff, MPH, PhD

Associate Professor - Johns Hopkins
Co-Director of the Epidemiology / Biostatistics Core of the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)

Joseph Eron, MD

Professor of Medicine and Epidemiology, Division of Infectious Diseases at UNC Chapel Hill, NC
Director of the Clinical Core for the UNC Center for AIDS Research (CFAR)

Greg Huhn, MD, MPHTM

Assistant Professor of Infectious Diseases - Rush University Medical Center, Chicago IL
Medical Director of the Ruth M Rothstein CORE Center, Chicago IL

Tony Mills, MD

Founder, CMO SoCal Men's Health
Director of Clinical Research, SoCal
Treats one of the largest population of HIV patients in Los Angeles, CA

Karam Mounzer, MD

Clinical Professor of Medicine - UPENN
Director of the Lax Center for the Treatment of Immune Disorders, the largest, community based HIV treatment center in Philadelphia

Graeme Moyle, MD, MB, MS, Dip GUM

Associate Specialist in HIV Medicine
Associate Director of HIV Research
Honorary Clinical Teacher in Medicine, Chelsea & Westminster Hospital

Paul Sax, MD

Professor of Medicine, Harvard Medical School
Clinical Director, Division of Infectious Diseases, Brigham and Women's Hospital, Boston MA

COMMITTEE MEMBER ACCOMPLISHMENTS

Publication
Journals

AIDS
The Lancet
JAIDS
PLOS | ONE
JAMA

Associations and
Foundations

CROI
IAS
HIVMA
AAHIVM
NIH
IDSA

Advisory Board
Affiliations

Gilead
AbbVie
Bristol-Myers Squibb
ViiV
Janssen
Merck

Publications

2019

Access to Direct Acting Antiviral Agents in HIV/HCV Co-Infected Population in the US

Dushyantha Jayaweera, Keri Althoff, Joseph Eron, Gregory Huhn, Janna Radtchenko, Scott Milligan, Anthony Mills, Graeme Moyle, Steven Santiago, Paul Sax, Jason Gillman, Karam Mounzer and Rick Elion

Poster Presented at: The European Association for the Study of the Liver (EASL)

Conference dates: April 10, 2019 - April 14, 2019

Weight Gain During Treatment Among 3,468 Treatment-Experienced Adults with HIV

Grace A McComsey, Joseph J Eron, Steven Santiago, Karam Mounzer, Graeme Moyle, Thanes Vanig, Paul E Sax, Keri N Althoff, Scott Milligan, Richard, Haubrich and Richard A Elion

Poster Presented at: Conference on Retroviruses and Opportunistic Infections (CROI)

Conference dates: March 4, 2019 - March 7, 2019

Weight Gain During Treatment Among 3,468 Treatment-Experienced Adults with HIV

Grace A McComsey, Joseph J Eron, Steven Santiago, Karam Mounzer, Graeme Moyle, Thanes Vanig, Paul E Sax, Keri N Althoff, Scott Milligan, Richard, Haubrich and Richard A Elion

Oral Presented at: Conference on Retroviruses and Opportunistic Infections (CROI)

Conference dates: March 4, 2019 - March 7, 2019

2018

Clinical Observations of Antiretroviral (ART) Switching in HIV-Suppresed Patients After Availability of TAF

Richard Elion, Joseph Eron, Steven Santiago, Paul Sax, Moti Rampogal, Greg Huhn, Scott Milligan, Keri Althoff and Jonathan Winston

Poster Presented at: HIV Glasgow

Conference dates: October 28, 2018 - October 31, 2018

Untreated HCV in HIV/HCV Co-Infection: Data from the TRIO Network

Dushwantha Jayaweera, Joseph Eron, Gregory Huhn, Scott Milligan, Anthony Mills, Graeme Moyle, Steven Santiago, Paul Sax, Gene Voskuhl, David Wyles, Karam Mounzer and Rick Elion

Poster Presented at: Digestive Disease Week (DDW)

Conference dates: June 2, 2018 - June 5, 2018

Behavioral and Clinical Factors and Direct Acting Antiviral (DAA) Effectiveness in HCV/HIV Co-Infection: Clinical Experience from the TRIO Network

Rick Elion, Gregory Huhn, Dushyantha Jayaweera, Keri Althoff, Joseph Eron, Scott Milligan, Anthony Mills, Graeme Moyle, Steven Santiago, Paul Sax, Gene Voskuhl, David Wyles and Karam Mounzer

Oral Presented at: Digestive Disease Week (DDW)

Conference dates: June 2, 2018 - June 5, 2018

Untreated HCV in HIV/HCV Co-Infection: Data from the TRIO Network

Dushyantha Jayaweera, Keri Althoff, Joseph Eron, Gregory Huhn, Scott Milligan, Anthony Mills, Graeme Moyle, Steven Santiago, Paul Sax, Gene Voskuhl, David Wyles, Karam Mounzer and Rick Elion

Poster Presented at: The European Association for the Study of the Liver (EASL)

Conference dates: April 11, 2018 - April 15, 2018

Behavioral and Clinical Factors and Direct Acting Antiviral Effectiveness in HCV/HIV Co-Infection: Clinical Experience from the TRIO Network

Gregory Huhn, Dushyantha Jayaweera, Keri Althoff, Joseph Eron, Scott Milligan, Anthony Mills, Graeme Moyle, Steven Santiago, Paul Sax, Gene Voskuhl, David Wyles, Karam Mounzer and Rick Elion

Poster Presented at: The European Association for the Study of the Liver (EASL)

Conference dates: April 11, 2018 - April 15, 2018

HIV

HIV

FOR EACH DISEASE, TRIO DEVELOPS A CUSTOM SOLUTION THAT CAPTURES PATIENT LEVEL DATA THROUGHOUT THE PATIENT JOURNEY, ALL IN REAL-TIME. TRIO’S COVERAGE INCLUDES APPROVED DRUG REGIMENS, PHYSICIANS AND PHARAMACIES WITHOUT BIAS.

Data Elements

DEMOGRAPHICS

LABS

PRIOR HISTORY

COMORBIDS

PROVIDERS

PAYERS

PA TIMELINE

DISPENSING INFO

Steering Committee

Rick Ellion, MD

Keri Althoff, MPH, PhD

Joseph Eron, MD

Greg Huhn, MD, MPHTM

Tony Mills, MD

Karam Mounzer, MD

Graeme Moyle, MD, MB, MS, Dip GUM

Paul Sax, MD

COMMITTEE MEMBER ACCOMPLISHMENTS

Publication
Journals

Associations and
Foundations

Advisory Board
Affiliations

Publications

2019

Access to Direct Acting Antiviral Agents in HIV/HCV Co-Infected Population in the US

Weight Gain During Treatment Among 3,468 Treatment-Experienced Adults with HIV

Weight Gain During Treatment Among 3,468 Treatment-Experienced Adults with HIV

2018

Clinical Observations of Antiretroviral (ART) Switching in HIV-Suppresed Patients After Availability of TAF

Untreated HCV in HIV/HCV Co-Infection: Data from the TRIO Network

Behavioral and Clinical Factors and Direct Acting Antiviral (DAA) Effectiveness in HCV/HIV Co-Infection: Clinical Experience from the TRIO Network

Untreated HCV in HIV/HCV Co-Infection: Data from the TRIO Network

Behavioral and Clinical Factors and Direct Acting Antiviral Effectiveness in HCV/HIV Co-Infection: Clinical Experience from the TRIO Network

HIV

HIV

​FOR EACH DISEASE, TRIO DEVELOPS A CUSTOM SOLUTION THAT CAPTURES PATIENT LEVEL DATA THROUGHOUT THE PATIENT JOURNEY, ALL IN REAL-TIME. TRIO’S COVERAGE INCLUDES APPROVED DRUG REGIMENS, PHYSICIANS AND PHARAMACIES WITHOUT BIAS.

Data Elements

DEMOGRAPHICS

LABS

PRIOR HISTORY

COMORBIDS

PROVIDERS

PAYERS

PA TIMELINE

DISPENSING INFO

Steering Committee

Rick Ellion, MD

Keri Althoff, MPH, PhD

Joseph Eron, MD

Greg Huhn, MD, MPHTM

Tony Mills, MD

Karam Mounzer, MD

Graeme Moyle, MD, MB, MS, Dip GUM

Paul Sax, MD

COMMITTEE MEMBER ACCOMPLISHMENTS

Publication Journals

Associations andFoundations

Advisory Board Affiliations

Publications

2019

Access to Direct Acting Antiviral Agents in HIV/HCV Co-Infected Population in the US

Weight Gain During Treatment Among 3,468 Treatment-Experienced Adults with HIV

Weight Gain During Treatment Among 3,468 Treatment-Experienced Adults with HIV

2018

Clinical Observations of Antiretroviral (ART) Switching in HIV-Suppresed Patients After Availability of TAF

Untreated HCV in HIV/HCV Co-Infection: Data from the TRIO Network

Behavioral and Clinical Factors and Direct Acting Antiviral (DAA) Effectiveness in HCV/HIV Co-Infection: Clinical Experience from the TRIO Network

Untreated HCV in HIV/HCV Co-Infection: Data from the TRIO Network

Behavioral and Clinical Factors and Direct Acting Antiviral Effectiveness in HCV/HIV Co-Infection: Clinical Experience from the TRIO Network

FOR EACH DISEASE, TRIO DEVELOPS A CUSTOM SOLUTION THAT CAPTURES PATIENT LEVEL DATA THROUGHOUT THE PATIENT JOURNEY, ALL IN REAL-TIME. TRIO’S COVERAGE INCLUDES APPROVED DRUG REGIMENS, PHYSICIANS AND PHARAMACIES WITHOUT BIAS.

Publication
Journals

Associations and
Foundations

Advisory Board
Affiliations